Before the COVID-19 pandemic, telemedicine largely was underutilized in dermatology. Vincent A. DeLeo, MD, of the University of Southern California, Los Angeles, and George Han, MD, PhD, of the Icahn School of Medicine at Mount Sinai, New York, discuss the expansion of telemedicine and dermatology resulting from the COVID-19 pandemic. The reimbursement process has changed and barriers have been encountered with the expansion of telemedicine. Dr Han notes that telemedicine represents the opportunity to expand access to care, particularly in populations that are underserved, with lower socioeconomic status, and skin of color.